PSMD10 and endometrial carcinoma: Previous findings showed that Gankyrin was negatively or weakly expressed in some normal tissues, but its protein level was increased in a range of tumor tissues, including hepatocellular carcinoma, esophageal squamous cell carcinoma, breast carcinoma and endometrial carcinoma [4]–[7].